echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > Leukemia: Family history of plasma cell disease is associated with increased survival rates for MGUS, multiple myeloma, and systemic AL amyloidosis

    Leukemia: Family history of plasma cell disease is associated with increased survival rates for MGUS, multiple myeloma, and systemic AL amyloidosis

    • Last Update: 2021-12-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The relationship between familial plasma cell disease (PCD) and monoclonal antibody disease (MGUS), multiple myeloma (MM), and systemic light chain (AL) amyloidosis has not been well described


    The relationship between familial plasma cell disease (PCD) and monoclonal antibody disease (MGUS), multiple myeloma (MM), and systemic light chain (AL) amyloidosis has not been well described


    Therefore, a foreign research team retrospectively reviewed the results of 25,423 patients (16,744 MGUS, 6194 MM, 2955 AL amyloidosis)


    Therefore, a foreign research team retrospectively reviewed the results of 25,423 patients (16,744 MGUS, 6194 MM, 2955 AL amyloidosis)


    Familial association of a proband who reports a family history of PCD

    The overall survival of patients with a family history of PCD and those without a family history of PCD

    The overall survival of patients with a family history of PCD and those without a family history of PCD The overall survival of patients with a family history of PCD and those without a family history of PCD Expect

    Overall, 2.


    Overall, 2.


    The cumulative incidence of MGUS progression to MM, a lymphoproliferative disease, or systemic AL amyloidosis, and death as a competitive risk MGUS progression to MM, a lymphoproliferative disease, or the accumulation of systemic AL amyloidosis Incidence rate, using death as a competitive risk

    Although studies have shown that family history of PCD may increase the risk of disease progression, there is currently no data showing that MGUS screening can improve health outcomes


    Although studies have shown that family history of PCD may increase the risk of disease progression, there is currently no data showing that MGUS screening can improve health outcomes


    Original source:

    Original source:

    Visram, A.


    Visram, A.




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.